Financials 3B Blackbio Dx Limited

Equities

KILPEST6

INE994E01018

Agricultural Chemicals

Market Closed - Bombay S.E. 03:00:43 2024-05-18 am EDT 5-day change 1st Jan Change
798.2 INR 0.00% Intraday chart for 3B Blackbio Dx Limited +12.94% +1.10%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 856.4 483.8 544.7 2,138 2,562 3,121
Enterprise Value (EV) 1 898.6 512 486.1 1,807 2,299 2,549
P/E ratio 24.9 x 9.21 x 7.07 x 1.87 x 7.94 x 12 x
Yield 0.37% 0.66% 0.96% 0.35% 0.73% 0.6%
Capitalization / Revenue 3.65 x 2.01 x 1.79 x 0.93 x 2.93 x 4.52 x
EV / Revenue 3.83 x 2.13 x 1.6 x 0.79 x 2.63 x 3.69 x
EV / EBITDA 15.8 x 6.43 x 4.45 x 1.18 x 5.22 x 7.01 x
EV / FCF -144 x 37.4 x 10.1 x 2.36 x 7.84 x 15.6 x
FCF Yield -0.69% 2.67% 9.87% 42.3% 12.8% 6.43%
Price to Book 4.66 x 2.15 x 1.69 x 1.62 x 1.67 x 1.82 x
Nbr of stocks (in thousands) 6,408 6,408 7,508 7,508 7,508 7,508
Reference price 2 133.6 75.50 72.55 284.7 341.2 415.7
Announcement Date 8/29/18 8/27/19 9/1/20 8/28/21 8/27/22 8/29/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 234.9 240.2 304.7 2,296 875.5 690.6
EBITDA 1 57.03 79.62 109.2 1,529 440 363.7
EBIT 1 52.46 74.14 103.8 1,523 433.3 355.1
Operating Margin 22.33% 30.87% 34.06% 66.31% 49.49% 51.41%
Earnings before Tax (EBT) 1 45.16 69.51 100.5 1,520 432.2 353.1
Net income 1 34.26 52.42 76.87 1,139 322 259.4
Net margin 14.59% 21.82% 25.23% 49.59% 36.78% 37.56%
EPS 2 5.367 8.201 10.26 152.0 42.98 34.62
Free Cash Flow 1 -6.221 13.67 47.96 764.9 293.1 163.8
FCF margin -2.65% 5.69% 15.74% 33.31% 33.48% 23.72%
FCF Conversion (EBITDA) - 17.17% 43.93% 50.03% 66.61% 45.04%
FCF Conversion (Net income) - 26.08% 62.39% 67.17% 91.02% 63.16%
Dividend per Share 2 0.5000 0.5000 0.7000 1.000 2.500 2.500
Announcement Date 8/29/18 8/27/19 9/1/20 8/28/21 8/27/22 8/29/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 42.1 28.2 - - - -
Net Cash position 1 - - 58.6 331 264 572
Leverage (Debt/EBITDA) 0.7386 x 0.3538 x - - - -
Free Cash Flow 1 -6.22 13.7 48 765 293 164
ROE (net income / shareholders' equity) 23% 25.4% 27% 125% 20.1% 14.1%
ROA (Net income/ Total Assets) 11.7% 13.9% 16% 79.9% 14% 10.9%
Assets 1 292.9 377.5 480.9 1,426 2,293 2,373
Book Value Per Share 2 28.70 35.10 42.90 176.0 204.0 228.0
Cash Flow per Share 2 2.470 5.260 12.50 46.70 38.50 78.90
Capex 1 10.3 7.18 5.35 16.8 22.6 20.2
Capex / Sales 4.38% 2.99% 1.76% 0.73% 2.59% 2.93%
Announcement Date 8/29/18 8/27/19 9/1/20 8/28/21 8/27/22 8/29/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. KILPEST6 Stock
  4. Financials 3B Blackbio Dx Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW